Skip to main content
. Author manuscript; available in PMC: 2016 Sep 21.
Published in final edited form as: J Parkinsons Dis. 2015;5(4):783–792. doi: 10.3233/JPD-150682

Table 2.

Results from the multiple regression analysis, all PD patients included

Composite cognition Executive/attention Visuospatial function Memory

Step Predictor Beta P Beta p Beta p Beta p
1. abeta42 0.071 0.189 0.068 0.211 0.067 0.220 0.020 0.719
t-tau −0.187 0.006 −0.216 0.001 −0.181 0.008 −0.128 0.062
p-tau181 0.038 0.487 0.050 0.364 −0.008 0.891 0.028 0.618
α-synuclein 0.165 0.014 0.174 0.009 0.161 0.016 0.136 0.044
2. Abeta42 −0.015 0.752 −0.005 0.922 0.064 0.214 −0.055 0.259
T-tau −0.058 0.327 −0.084 0.172 −0.094 0.155 −0.023 0.715
P-tau181 0.029 0.525 0.037 0.443 −0.026 0.612 0.022 0.657
α-synuclein 0.132 0.019 0.137 0.020 0.118 0.058 0.109 0.068
Gender (1 = F, 2 =M) −0.251 <0.001 −0.153 <0.001 0.230 <0.001 −0.246 <0.001
Age (in years) −0.382 <0.001 −0.372 <0.001 −0.132 0.009 −0.323 <0.001
Education (in years) 0.294 <0.001 0.294 <0.001 0.238 <0.001 0.256 <0.001
UPDRS III total −0.104 0.014 −0.062 0.158 −0.116 0.014 −0.085 0.057

Results from the multiple linear regression models of the effects of CSF markers on cognition in the PD patients. In step 1 only the CSF markers were included as predictors vs composite cognition and the cognitive domains as dependent variables. In step 2 potential confounding variables were added. Only patients without missing values were included in the analyses, n = 403 (5 excluded to due to extreme α-synuclein values, two due to missing p-tau, 4 due to missing t-tau results.). The reported beta-values are standardized.